JCO Precis Oncol 2017 May 4;1. Epub 2017 May 4.
, , , , , , , , , and , Thomas Jefferson University; , , , , , , and , Fox Chase Cancer Center, Philadelphia, PA; and , Myriad Genetics, Salt Lake City, UT.
Purpose: Multigene panels are commercially available for the evaluation of prostate cancer (PCA) predisposition, which necessitates tailored genetic counseling (GC) for men. Here we describe emerging results of Genetic Evaluation of Men, prospective multigene testing study in PCA to inform personalized genetic counseling, with emerging implications for referrals, cancer screening, and precision therapy.
Patients And Methods: Eligibility criteria for men affected by or at high risk for PCA encompass age, race, family history (FH), and PCA stage/grade. Read More